Vaccinated patients hospitalized with COVID-19 who developed acute kidney injury had better outcomes than unvaccinated patients with the same condition, new research suggests.
Vaccinated patients hospitalized with COVID-19 who developed acute kidney injury had better outcomes than unvaccinated patients with the same condition, new research suggests.
Read More
Physical well-being, by contrast, returned after three months; up to 20% of patients continued experiencing suboptimal overall health-related quality of life one year after infection.
Read More
A novel approach to address the global issue of discarded face masks converts them into high-value products such as carbon nanotubes and hydrogen.
Read More
American College of Physicians leaders warn that abrupt changes to COVID-19 vaccine recommendations could jeopardize payment coverage and place millions of Americans at risk.
Read More
Infants hospitalized with severe COVID-19 have significantly different immune responses than adults or older children, according to research published in Nature Communications.
Read More
SARS-CoV-2, the virus that causes COVID-19, can “reprogram” pathogen-fighting white blood cells known as neutrophils into immune system suppressing cells known as PMN-MDSCs.
Read More
Moderna’s biologics license application for its flu/COVID combination vaccine candidate for adults aged 50 years and older.
Read More
Elevated sCD13 levels in COVID-19 patients’ lungs are associated with severe complications like respiratory failure and blood clot formation.
Read More
There is no association between the COVID-19 vaccine and miscarriage, a new Obstetrics and Gynecology study confirms.
Read More
Patients suffering from long COVID may exhibit persistent inflammation in the heart and lungs for up to a year following SARS-CoV-2 infection
Read More
Up to two years after infection, long COVID significantly increases children’s risks of chronic kidney disease, gastrointestinal issues, and cardiovascular conditions.
Read More
Nasal bacteria can affect the levels of key proteins the SARS-CoV-2 virus needs to enter human cells and may explain why some individuals are more susceptible to COVID-19 infection.
Read More
The United States prevented far more in medical spending and lost-productivity than it spent on testing, buying and delivering the COVID-19 vaccines.
Read More
A recent CDC statement may signal a shift in the agency’s longstanding practice of advocating vaccinations for infectious diseases like measles.
Read More
In laboratory testing, new drug candidate Jun13296 remained effective against Paxlovid-resistant strains of the coronavirus SARS-CoV-2.
Read More
Researchers have developed a universal vaccine that targets coronaviruses and the sugars that they use as cover.
Read More
The guidelines provide around 100 evidence-based recommendations for preventing and treating long COVID, which affects a reported one million Canadians.
Read More
Five years ago, on March 11, 2020, the World Health Organization declared the coronavirus SARS-CoV-2 a global pandemic.
Read More
The phase 2 The AeroVax study will evaluate the safety and effectiveness of a novel inhaled COVID-19 vaccine.
Read More
Visby Medical’s handheld PCR test that differentiates between influenza A, B, and COVID-19 received FDA clearance and a CLIA waiver.
Read More
Paxlovid does not significantly reduce COVID-19 hospitalization and mortality among vaccinated older adults, according to UCLA-led research.
Read More
COVID-19 infection may be associated with an increase in the number of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases.
Read More
The FDA approved an investigational new drug application from Ocugen Inc for a nasal COVID-19 vaccine that will begin a Phase 1 clinical trial.
Read More
Retinal imaging could offer new perspectives on long COVID’s impact.
Read More
